Still Not Enough Naloxone Where It's Most Needed
The overdose-reversing drug naloxone saves lives – but only if it's readily available when an overdose occurs.
Despite a huge increase in naloxone prescribing in recent years, CDC researchers report in the latest Vital Signs study that far too little naloxone is being dispensed in many areas of the country that need it the most.... read more
PvPI study reveals major suspected ADRs in anti-retroviral drugs like lamivudine, efavirenz and tenofovir
The Pharmacovigilance Programme of India (PvPI)'s recent study has revealed that major suspected adverse drug reactions (ADRs) have originated from anti-retroviral drugs like lamivudine, efavirenz and tenofovir. Ever since its inception in April 2011, PvPI has been receiving reports from healthcare professionals, industry and consumers. Data-mining was done to identify the most occurring reactions with associated medicines.... read more
Three Congolese doctors arrested in connection with WHO official's death
GOMA, DRC - Three Congolese doctors have been arrested for allegedly planning an attack on a hospital that killed a senior World Health Organization (WHO) epidemiologist involved in the Ebola response, a prosecutor said on Wednesday.
Cameroonian doctor Richard Mouzoko was killed in an attack in April on a hospital in the city of Butembo,... read more
India, China, Nigeria, Pakistan, Indonesia face largest burden of childhood cancer: Study
Children in the poorest countries face a disproportionately high cancer burden — contributing over 82% of the global childhood cancer burden - equivalent to almost 9.5 million years of healthy life lost in 2017. Most (97%) of this global burden is related to premature death, with around 3% due to impaired quality of life,... read more
FDA Approves Oral Ferric Maltol for Iron Deficiency in Adults
The US Food and Drug Administration (FDA) has approved oral ferric maltol (Accrufer, Shield Therapeutics) for the treatment of iron deficiency in adults.
The product is already approved in the European Union and Switzerland for the treatment of iron deficiency in adults, where it is sold as Feraccru.
... read more
CBT Best First-Line Treatment for Major Depression in Youth?
Adding an antidepressant to cognitive behavioral therapy (CBT) appears to provide no additional benefit over CBT alone in reducing symptoms in youth with major depression, suggests new research published online July 29 in Lancet Psychiatry.
Investigators compared 12 weeks of treatment with a combination of CBT and the selective serotonin reuptake inhibitor fluoxetine to CBT plus placebo in 153 youth (aged 15 to 25 years) with moderate-to-severe major depressive disorder (MDD)... read more